Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Ann Epidemiol. 2016 Jul 18;26(9):654–662. doi: 10.1016/j.annepidem.2016.07.004

TABLE 1.

Age-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) comparing characteristics of ovarian cancer cases and controls stratified by menopausal status, the African American Cancer Epidemiology Study (AACES), 2010–2016.

Pre-menopausal Post-menopausal All Women
Cases
n=175
n (%)
Controls
n=224
n (%)
OR 95% CI Cases
n=466
n (%)
Controls
n=528
n (%)
OR 95% CI Cases
n=641
n (%)
Controls
n=752
n (%)
OR 95% CI
Age
  20 – 29 7 (4.0) 22 (9.8) 1 (0.2) 1 (0.2) 8(1.3) 23 (3.1)
  30 – 39 27 (15.4) 55 (24.6) 1 (0.2) 2 (0.4) 28(4.4) 57 (7.6)
  40 – 49 90 (51.4) 99 (44.2) 20 (4.3) 22 (4.2) 110 (17.2) 121 (16.1)
  50 – 59 48 (27.4) 46 (20.5) 165 (35.4) 235 (44.5) 213 (33.2) 281 (37.4)
  60 – 69 3 (1.7) 2 (0.9) 177 (38.0) 193 (36.6) 180 (28.1) 195 (25.9)
  70 – 79 102 (21.9) 75 (14.2) 102 (15.9) 75 (10.0)
Education
  ≤ High school graduate 69 (39.4) 69 (30.8) 1.0 Reference 214 (45.9) 211 (40.0) 1.0 Reference 283 (44.2) 280 (37.3) 1.0
  Some post-high school 56 (32.0) 84 (37.5) 0.7 (0.4–1.1) 149 (32.0) 182 (34.5) 0.9 (0.7–1.2) 205 (32.0) 266 (35.4) 0.8 (0.7–1.1)
  ≥ College graduate 50 (28.6) 71 (31.7) 0.8 (0.4–1.3) 103 (22.1) 134 (25.4) 0.8 (0.06–1.1) 153(23.9) 205 (27.3) 0.8 (0.6–1.1)
  Missing 1 1
Family history of breast
or ovarian cancer (1st
degree)
  No 128 (75.3) 194 (89.0) 1.0 Reference 333 (73.0) 400 (78.4) 1.0 Reference 461 (73.6) 594 (81.6) 1.0 Reference
  Yes 42 (24.7) 24 (11.0) 2.4 (1.3–4.2) 123 (27.0) 110 (21.6) 1.4 (1.0–1.9) 165 (26.4) 134 (18.4) 1.6 (1.2–2.1)
  Missing 5 6 10 18 15 24
Age at menarche (years)
  <12 46 (26.3) 57 (25.5) 1.0 Reference 100 (21.5) 143 (27.1) 1.0 Reference 146 (22.8) 200 (26.6) 1.0 Reference
  12 – 13 87 (49.7) 113 (50.5) 0.9 (0.6–1.6) 239 (51.3) 249 (47.2) 1.3 (1.0–1.8) 326 (50.9) 362 (48.1) 1.2 (0.9–1.6)
  >13 42 (24.0) 54 (24.1) 0.9 (0.5–1.7) 127 (27.3) 136 (25.8) 1.2 (0.9–1.8) 169(26.4) 190 (25.3) 1.1 (0.8–1.5)
Age at menopause (yrs)
  <45 85 (19.0) 110 (21.1) 1.0 Reference
  45 – 49 108 (24.2) 135 (25.9) 1.0 (0.7–1.5)
  50 – 54 182 (40.7) 203 (39.0) 1.1 (0.7–1.5)
  >54 72 (16.1) 73 (14.0) 1.1 (0.7–1.7)
  Missing 19 7
Tubal Ligation
  No 122 (69.7) 148 (66.1) 1.0 Reference 297 (64.0) 301 (57.1) 1.0 Reference 419 (65.6) 449 (59.8) 1.0 Reference
  Yes 53 (30.3) 76 (33.9) 0.6 (0.6–1.0) 167 (36.0) 226 (42.9) 0.7 (0.6–1.0) 220 (34.4) 302 (40.2) 0.7 (0.6–0.9)
  Missing 2 1 2 1
Doctor diagnosed female
infertility
  No 127 (85.2) 195 (92.4) 1.0 Reference 396 (89.0) 461 (92.2) 1.0 Reference 523 (88.1) 656 (92.3) 1.0 Reference
  Yes 22 (14.8) 16 (7.6) 2.5 (1.2–5.3) 49 (11.0) 39 (7.8) 1.6 (1.0–2.6) 71 (12.0) 55 (7.7) 1.9 (1.3–2.8)
  Missing 26 13 21 28 47 41
Body mass index (kg/m2)
1 year prior to diagnosis/
interview
0.25 0.11 0.11
  <25 27 (15.6) 46 (20.5) 1.0 Reference 63 (13.6) 95 (18.0) 1.0 Reference 90 (14.1) 141 (18.8) 1.0 Reference
  25 – <30 47 (27.2) 48 (21.4) 1.4 (0.7–2.8) 120 (25.9) 150 (28.5) 1.2 (0.8–1.8) 167 (26.2) 198 (26.4) 1.3 (0.9–1.8)
  30 – <35 49 (28.3) 54 (24.1) 1.4 (0.7–2.7) 130 (28.0) 135 (25.6) 1.4 (0.9–2.1) 179 (28.1) 189 (25.2) 1.4 (1.0–2.0)
  ≥35 50 (28.9) 76 (33.9) 0.9 (0.5–1.7) 151 (32.5) 147 (27.9) 1.6 (1.1–2.4) 201 (31.6) 223 (29.7) 1.4 (1.0–2.0)
  Missing 2 2 1 4 1
Histology
  Serous 84 (52.2) 271 (62.9) <0.0001 355(60.0)
  Endometrioid 31 (19.3) 44 (10.2) 75(12.7)
  Mucinous 17 (10.6) 13 (3.0) 30(5.1)
  Clear cell 5 (3.1) 8 (1.9) 13(2.2)
  Other 24 (14.9) 95 (22.0) 119(20.1)
  Missing 14 35 48

p-value comparing histology in pre-menopausal versus postmenopausal cases.